Institutions / Eversept Partners, LP
Eversept Partners, LP
CIK 1697013 · Institution · as of Dec 31, 2025
Portfolio value
$1.78B
Positions
103
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 103 →
| Company | Value | % of portfolio |
|---|---|---|
| Vera Therapeutics, Inc. | $155.58M | 8.7% |
| Gsk PLC | $131.41M | 7.4% |
| United Therapeutics Corp | $123.08M | 6.9% |
| Abivax SA | $88.71M | 5.0% |
| Natera, Inc. | $76.63M | 4.3% |
| Syndax Pharmaceuticals Inc | $69.64M | 3.9% |
| Viridian Therapeutics, Inc. | $55.46M | 3.1% |
| Vaxcyte, Inc. | $55.26M | 3.1% |
| Travere Therapeutics, Inc. | $44.90M | 2.5% |
| HCA Healthcare, Inc. | $44.76M | 2.5% |
| Danaher Corp /De | $42.64M | 2.4% |
| Ionis Pharmaceuticals Inc | $42.58M | 2.4% |
| Celldex Therapeutics, Inc. | $38.97M | 2.2% |
| Bruker Corp | $36.92M | 2.1% |
| Avantor, Inc. | $36.40M | 2.0% |
| Community Health Systems Inc | $24.78M | 1.4% |
| Exact Sciences Corp. | $24.54M | 1.4% |
| Biocryst Pharmaceuticals Inc | $23.34M | 1.3% |
| Geron Corp | $23.31M | 1.3% |
| BIO-TECHNE Corp | $22.20M | 1.2% |
| Cidara Therapeutics Inc | $21.81M | 1.2% |
| Insulet Corp | $21.24M | 1.2% |
| Beta Bionics, Inc. | $20.67M | 1.2% |
| Teva Pharmaceutical Industries LtdTEVA | $20.60M | 1.2% |
| Unitedhealth Group Inc | $20.09M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.